Clear Scans… but still wondering “is it gone?”
After cancer treatment ends, many women are left with a quiet, persistent question:How do I know if the cancer is really gone?
In this episode of The Flourish After Cancer Podcast, I teach about more modern and advanced post-treatment testing — including blood tests that can sometimes detect cancer-related signals earlier than scans.
This episode is designed to help you:
Exhale and step out of constant vigilance
Understand what these tests are actually telling you (and what they aren’t)...
Clear Scans… but still wondering “is it gone?”
After cancer treatment ends, many women are left with a quiet, persistent question:
How do I know if the cancer is really gone?
In this episode of The Flourish After Cancer Podcast, I teach about more modern and advanced post-treatment testing — including blood tests that can sometimes detect cancer-related signals earlier than scans.
This episode is designed to help you:
- Exhale and step out of constant vigilance
- Understand what these tests are actually telling you (and what they aren’t)
- Learn how to think about recurrence monitoring without living in fear
This is a grounded, science-informed conversation about clarity — not chasing certainty.
🔗 Episode Relevant Resources
- The First 4 Steps To Staying Cancer Free After Cancer: www.FlourishAfterCancer.com/Presentation
- Work with us! Visit www.FlourishAfterCancer.com/NextSteps to learn more
- Natera company (Signatera test for ctDNA - no affiliations): www.natera.com
- RGCC testing (no affiliations): www.rgcc-international.com/tests
⚠️ This is a must-listen if:
- You’ve been told your scans are “clear,” but still don’t feel fully at ease
- You’ve heard about blood tests that can detect cancer sooner than imaging
- You’re wondering if you should be monitoring more than you currently are
- You feel anxious between follow-ups or scans
- You want to reduce recurrence risk without living test-to-test
✨ In this episode, you’ll learn:
- Why there is no single test that can prove cancer is “truly gone”
- What molecular residual disease (MRD) actually means in plain language
- How blood-based monitoring tools differ (ctDNA, CTCs, and tumor markers)
- Where tumor-informed ctDNA tests (like Signatera) fit — and where they don’t
💡 You’ll leave this episode with:
- A calmer, clearer understanding of post-treatment testing
- Less pressure to chase certainty through constant monitoring
- A framework for deciding when MRD testing is helpful — and when it isn’t
- More confidence in how to think about “clear scans” and blood tests
- A grounded mindset around recurrence prevention that supports both your body and your nervous system
I’m Dr Megan, a licensed naturopathic doctor. My team and I have worked with hundreds of women globally to rebuild their health after cancer and reduce recurrence risk using research-backed nutrition, lifestyle strategies, functional testing, and individualized support — so they can feel strong, confident, and free to enjoy their lives again.
✨ Let’s Connect!
Book a free Roadmap Call and let’s talk through what support could look like for you:
👉 https://flourishaftercancer.com/nextsteps
Follow me:
Instagram: @MeganBernardND
Facebook: @MeganBernardND
Website: https://flourishaftercancer.com/
Medical Disclaimer:
The information provided in these videos and podcasts is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare provider before making changes to your diet, medications, supplements, or lifestyle. This content is not a substitute for professional medical advice or care.
View more